Securities Code: 002932
Securities Abbreviation: *ST Mingde
Announcement Number: 2026-057
Wuhan Mingde Bio-technology Co., Ltd.
Announcement on Amendments to the Report on Major Asset Purchase (Draft)
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Wuhan Mingde Bio-technology Co., Ltd. (hereinafter referred to as the "Company") intends to acquire 100% equity of Wuhan Aikair Rescue Products Co., Ltd. held by Blue Sail Medical Co., Ltd. through cash payment (hereinafter referred to as the "Transaction").
Given that the audit base date for the Transaction has been updated to March 31, 2026, the Company, together with relevant intermediaries, has revised, supplemented, and improved the "Report on Major Asset Purchase (Draft) of Wuhan Mingde Bio-technology Co., Ltd." For specific details, please refer to the "Report on Major Asset Purchase (Draft) (Revised Draft) of Wuhan Mingde Bio-technology Co., Ltd." (hereinafter referred to as the "Revised Draft of the Report") and other related documents disclosed on the same day as this announcement.